Zelgen(SH:688266) Xin Lang Cai Jing·2025-12-31 02:22Group 1 - The core viewpoint of the news is that Zai Lab's stock has shown a slight increase, with a current price of 93.18 yuan per share and a total market capitalization of 24.666 billion yuan [1] - Zai Lab, established on March 18, 2009, focuses on the research, production, and sales of chemical and biological new drugs, with 99.97% of its revenue coming from pharmaceuticals [1] - The company is headquartered in Kunshan, Jiangsu Province, and has been publicly listed since January 23, 2020 [1] Group 2 - Citic Prudential Fund has a significant holding in Zai Lab, with its fund "Citic Prudential Zhi Rui Mixed A" increasing its stake by 7,200 shares in the third quarter, bringing its total to 108,000 shares, which represents 4.72% of the fund's net value [2] - The fund has a total size of 142 million yuan and has achieved a year-to-date return of 4.4%, ranking 6,912 out of 8,085 in its category [2] - The fund manager, Wang Rui, has a tenure of 10 years and 249 days, with the best return during his tenure being 253.09% [3]